Stock Analiz

BDX vs MDLN stock comparison

Becton Dickinson & vs. Medline · data as of November 13, 2026

Becton Dickinson & (BDX) has a market value of about $59.4B, Medline (MDLN) about $51.9B. Over their latest twelve months Becton Dickinson & had revenue of $19.5B and Medline $30.7B.

On our five checks Becton Dickinson & scores higher: 2.0 out of 5 (weak) against 1.0 (weak).

By area, the stronger company is Becton Dickinson & on track record; Becton Dickinson & on shareholder returns.

Becton Dickinson & is cheaper on earnings (P/E 43.1 vs. 89.7).

Becton Dickinson & leads on 14 of the compared lines and Medline on 5.

Side by side

BDXMDLN
Size and price
Market cap$59.4B$51.9B
Share price$218.03$39.47
Score
Overall score (of 5)2.01.0
Value00
Future growth22
Track record20
Financial health22
Shareholder returns41
Valuation
P/E (TTM)43.189.7
Forward P/E17.526.2
Price / free cash flow22.027.4
Price / sales3.11.7
EV / EBITDA14.322.6
PEG2.61—
DCF value vs. price−41%−48%
Business
Revenue$19.5B$30.7B
Net income$1.1B$566M
Free cash flow$2.7B$1.9B
Net margin5.9%1.8%
Gross margin (5-yr avg.)44.6%26.4%
ROIC (5-yr avg.)4.8%8.6%
Growth
Revenue growth (1 yr)8.2%11.5%
Revenue growth (5 yrs, per year)6.3%—
EPS growth (5 yrs, per year)16.5%—
Balance sheet and payouts
Net cash (cash minus debt)-$16.1B-$9.1B
Dividend yield1.94%None
Shareholder yield3.6%0.1%
Analysts
Upside to average target+4%+15%
Consensus ratingBuyBuy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: BDX TTM to September 30, 2026, MDLN TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, Becton Dickinson & or Medline?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Becton Dickinson & scores 2.0 out of 5 and Medline 1.0; the table shows where each one is stronger.

Is Becton Dickinson & cheaper than Medline?

On trailing earnings, Becton Dickinson & trades at a P/E of 43.1 and Medline at 89.7, so Becton Dickinson & is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which pays a higher dividend?

Becton Dickinson & yields 1.94% and Medline nothing (no dividend).

Full Becton Dickinson & analysis → Full Medline analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.